At time of writing, the share price of Prospect Resources Ltd [ASX:PSC] is up 22.22%, trading at 22 cents. A wild ride for investors played out over the course of the last 12 months. The company announced today that it had signed a seven-year offtake agreement…
By Lachlann Tierney,
We should see some big moves in individual stocks on the ASX this week. Whether the ASX 200 moves up or down is yet to be seen. A lot of earnings are due and some will surely disappoint…
By Lachlann Tierney,
Whether it’s by directly holding Big Four bank shares or part of your super — a significant portion of Australians have a piece of the banking oligopoly pie. Today I discuss bank stocks relative to resources and the risk that CBDCs pose to traditional banking…
By Lachlann Tierney,
The share price of Appen Ltd (ASX:APX) is down .89% today at time of writing, trading at $36.85. The APX share price reflects the broader theme in the market where tech leaders are advancing relative to their peers…
By Lachlann Tierney,
Yes, there is an immense amount of stimulus in the system, and the financial system is looking strained. But the surging interest in BBOZ may have fooled some novice investors. The thinking is, well a crash happened, and the worst is yet to come…
By Lachlann Tierney,
Rooting for gold is like rooting for the apocalypse! I see it as more an inexorable trend than anything. Exponential means the gold price would need to go truly ballistic…
By Lachlann Tierney,
At time of writing, the share price of Galaxy Resources Ltd [ASX:GXY] is down 1.59%, to trade at $1.24 apiece. You can see the GXY share price spiked strongly starting in July then punched through resistance at around $1.10…
By Lachlann Tierney,
Thing is, the bears are still wrong. Their day in the sun, or the gloom I should say, may come. But there are reasons to be positive amongst all the supposedly conflicting signals. And I think the narrative that the bears are pushing leaves you with a very narrow…
By Lachlann Tierney,
The share price of oncology-focused biotech firm, KAZIA Therapeutics Ltd [ASX:KZA], soared this morning on the receipt of FDA designation for its brain cancer treatment. At time of writing the KZA share price is up 26 cents or 46.43%, trading at 82 cents per share.
By Lachlann Tierney,
The share price of Lynas Corporation Ltd [ASX:LYC] is down 2.44%, trading at $2.40. You can see how the Lynas share price bounced strongly off the March market lows. Today, the company updated investors on its proposed Malaysian processing plant…
By Lachlann Tierney,
Investment ideas from the edge of the bell curve.
Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.
All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.
The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988